Company / SG&A Expense
Vivani Medical, Inc. SG&A Expense History
FY2015-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$8.2M
FY2017
5-year range
$4.2M / $8.2M
FY2015-FY2017
Trend
+25.3%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $4M to $8M over the past 2 years.
Based on SEC 10-K filings.
$8M in FY2017.
Increased from $4M to $8M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2017, sg&a expense increased 25.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score -4.83 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | $8.2M | +25.3% |
| FY2016 | $6.6M | +57.5% |
| FY2015 | $4.2M | - |
As of FY2017 · SEC 10-K · Updated Jun 28, 2026